Overexpression of microRNAs-155 and 21 targeting mismatch repair proteins in inflammatory bowel diseases

Carcinogenesis

Volumn 34, Issue 4, 2013, Pages 828-834

  Svrcek, Magali ^a,b,c   El Murr, Nizar ^a,b   Wanherdrick, Kristell ^a,b   Dumont, Sylvie ^b   Beaugerie, Laurent ^b,d   Cosnes, Jacques ^b,d   Colombel, Jean Frédéric ^e,f   Tiret, Emmanuel ^b,d   Fléjou, Jean François ^a,b,c,d   Lesuffleur, Thécla ^a,b   Duval, Alex ^a,b  

^a CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d ARMAND TROUSSEAU HOSPITAL   (France)

^e LILLE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITÉ DE LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 155; MICRORNA 21; MISMATCH REPAIR PROTEIN;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA MISMATCH REPAIR; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MICRORNAS; MICROSATELLITE INSTABILITY; MIDDLE AGED; YOUNG ADULT;

EID: 84875963765     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs408     Document Type: Article

References (46)

1. Ekbom,A. et al.. (1990) Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med., 323, 1228-1233.
2. Gillen,C.D. et al.. (1994) Crohn's disease and colorectal cancer. Gut, 35, 651-655.
3. Gillen,C.D. et al.. (1994) Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut, 35, 1590-1592.
4. Rutter,M. et al.. (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology, 126, 451-459.
5. Ullman,T.A. et al.. (2011) Intestinal inflammation and cancer. Gastroenterology, 140, 1807-1816.
6. Schulmann,K. et al.. (2005) Molecular phenotype of inflammatory bowel disease-associated neoplasms with microsatellite instability. Gastroenterology, 129, 74-85.
7. Svrcek,M. et al.. (2007) Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability. J. Clin. Oncol., 25, 4231-4238.
8. Duval,A. et al.. (2002) Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability. Cancer Res., 62, 2447-2454.
9. Hampel,H. et al.. (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N. Engl. J. Med., 352, 1851-1860.
10. Truninger,K. et al.. (2005) Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology, 128, 1160-1171.
11. Aaltonen,L.A. et al.. (1993) Clues to the pathogenesis of familial colorectal cancer. Science, 260, 812-816.
12. Ionov,Y. et al.. (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature, 363, 558-561.
13. Thibodeau,S.N. et al.. (1993) Microsatellite instability in cancer of the proximal colon. Science, 260, 816-819.
14. Veigl,M.L. et al.. (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc. Natl. Acad. Sci. U.S.A., 95, 8698-8702.
15. Croce,C.M. (2009) Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet., 10, 704-714.
16. Esquela-Kerscher,A. et al.. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
17. Lujambio,A. et al.. (2012) The microcosmos of cancer. Nature, 482, 347-355.
18. Wu,W.K. et al.. (2011) MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis, 32, 247-253.
19. Valeri,N. et al.. (2010) Modulation of mismatch repair and genomic stability by miR-155. Proc. Natl. Acad. Sci. U.S.A., 107, 6982-6987.
20. Bakirtzi,K. et al.. (2011) Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors. Gastroenterology, 141, 1749-61.e1.
21. Ng,E.K. et al.. (2009) Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58, 1375-1381.
22. Volinia,S. et al.. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U.S.A., 103, 2257-2261.
23. Earle,J.S. et al.. (2010) Association of microRNA expression with microsatellite instability status in colorectal adenocarcinoma. J. Mol. Diagn., 12, 433-440.
24. Lanza,G. et al.. (2007) mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol. Cancer, 6, 54.
25. Sarver,A.L. et al.. (2009) Human colon cancer profiles show differential microRNA expression depending on mismatch repair status and are characteristic of undifferentiated proliferative states. BMC Cancer, 9, 401.
26. Luo,X. et al.. (2011) MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol. Biomarkers Prev., 20, 1272-1286.
27. Asangani,I.A. et al.. (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene, 27, 2128-2136.
28. Kim,Y.J. et al.. (2009) MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells, 27, 3093-3102.
29. Wickramasinghe,N.S. et al.. (2009) Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells. Nucleic Acids Res., 37, 2584-2595.
30. Valeri,N. et al.. (2010) MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc. Natl. Acad. Sci. U.S.A., 107, 21098-21103.
31. Tili,E. et al.. (2011) Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc. Natl. Acad. Sci. U.S.A., 108, 4908-4913.
32. Fasseu,M. et al.. (2010) Identification of restricted subsets of mature micro-RNA abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS ONE, 5, e13160.
33. Takagi,T. et al.. (2010) Increased expression of microRNA in the inflamed colonic mucosa of patients with active ulcerative colitis. J. Gastroenterol. Hepatol., 25 (suppl. 1), S129-S133.
34. Wu,F. et al.. (2010) Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm. Bowel Dis., 16, 1729-1738.
35. Buhard,O. et al.. (2004) Quasimonomorphic mononucleotide repeats for high-level microsatellite instability analysis. Dis. Markers, 20, 251-257.
36. Zaanan,A. et al.. (2011) Defective mismatch repair status as a prognostic biomarker of disease-free survival in stage III colon cancer patients treated with adjuvant FOLFOX chemotherapy. Clin. Cancer Res., 17, 7470-7478.
37. Svrcek,M. et al.. (2010) Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers. Gut, 59, 1516-1526.
38. Li,J. et al.. (2007) Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol., 7, 36.
39. Liu,A. et al.. (2011) MicroRNA isolation from formalin-fixed, paraffinembedded tissues. Methods Mol. Biol., 724, 259-267.
40. Xi,Y. et al.. (2007) Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA, 13, 1668-1674.
41. Zhang,X. et al.. (2008) An array-based analysis of microRNA expression comparing matched frozen and formalin-fixed paraffin-embedded human tissue samples. J. Mol. Diagn., 10, 513-519.
42. Krichevsky,A.M. et al.. (2009) miR-21: a small multi-faceted RNA. J. Cell. Mol. Med., 13, 39-53.
43. Liu,M. et al.. (2011) miR-21 targets the tumor suppressor RhoB and regulates proliferation, invasion and apoptosis in colorectal cancer cells. FEBS Lett., 585, 2998-3005.
44. Borie,C. et al.. (2009) The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms. Int. J. Cancer, 125, 2360-2366.
45. Duval,A. et al.. (2004) The mutator pathway is a feature of immunodeficiency-related lymphomas. Proc. Natl. Acad. Sci. U.S.A., 101, 5002-5007.
46. Tili,E. et al.. (2009) miR-155: on the crosstalk between inflammation and cancer. Int. Rev. Immunol., 28, 264-284.